• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Remix Therapeutics Remix Therapeutics
  • Science
  • People
  • Join Us
  • News & Media
  • Contact
  • Privacy Policy
  • Terms of Use

News and Media

Filter

All News Article Press Release Webcast
Page: 1 of 4
March 22, 2023
Press Release
Remix Therapeutics Appoints Robert Gagnon as Chief Financial Officer
January 5, 2023
Press Release
Remix Therapeutics Appoints Christopher Bowden, M.D., as Chief Medical Officer
December 8, 2022
Press Release
Remix Therapeutics to Present at 5th Annual RNA-Targeted Drug Discovery Summit
May 31, 2022
Press Release
Remix Therapeutics to Present at Jefferies Healthcare Conference
May 31, 2022
Webcast
Jefferies Healthcare Conference 2022: Remix Therapeutics Corporate Overview
Media Contact

Lissette Steele

Verge Scientific

Communications

202.930.4762

lsteele@vergescientific.com

Media Contact

Lissette Steele

Verge Scientific

Communications

202.930.4762

lsteele@vergescientific.com

sidebar

sidebar-alt

Footer

100 Forge Rd, Ste 400 Watertown, MA, 02472
© Remix Therapeutics 2023. All Rights Reserved

  • Privacy Policy
  • Terms of Use